Both Flt3L (p < 0.002) and CD40L (p < 0.04), which have each been shown to have immune-stimulatory and anti-tumor effects, increased significantly at PostIT compared to PreIT (Fig. 3, middle panel) [20]. This evidence concerns the gene CD40LG and neoplasm.